Gara Jalqabaatti › COPD › North Carolina
Qorannoo klinikaalii COPD North Carolina keessatti
Qorannoo 23 COPD f North Carolina keessatti hirmaatuu jiru.
Magaalota North Carolina keessatti
Takkalaa qorannoo (Ingiliffa)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
- GSK Investigational Site, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- Piedmont Healthcare - Family Medicine- Site Number : 8400022, Statesville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Carolina Research Center, Inc., Shelby
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07053423A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06878261A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of North Carolina Clinical Research Center, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 35 hanga 80 · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07363694Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07031336STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 30 hanga 55 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
Namoota walitti qabaa jira
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 28-Elb-2026 · NCT07051707Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Gur-2026 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 05-Hag-2025 · NCT06122077Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.